Vicki L. Goodman - Jan 4, 2022 Form 3 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP, Prod Dev & Med Aff &CMO
Signature
/s/ Christopher J. Senner, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 06:58 PM
Next filing
Feb 17, 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney